Forecast & Rating4 analysts currently cover Polaryx Therapeutics, of which 4 give a positive rating. The average price target is $7.50, about 248.8% upside from the current price of $2.15. Coverage is limited, so the data is for reference only. Data as of Aug 15, 2026; this does not constitute investment advice.
Aug 14, 2026Price forecast
$7.50248.84%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 22, 2026
Forecast met0.0%
Stock price$2.15
Avg. target$7.5
High target$10
Low target$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.